Vince Martin
Long/short equity, value, gambling

Cumberland Pharmaceuticals: A Rare Value Stock In The Drug Industry

It's not often you come across a true value stock in the pharmaceutical sector. There are more than a few stocks in the sector that come up on a variety of standard value screens -- price-to-cash, price-to-book, NCAV -- but those are generally biotech or early-stage development companies which are burning through significant amounts of their seemingly impressive asset bases.

It's what makes Cumberland Pharmaceuticals (NASDAQ:CPIX) so surprising. The stock closed Friday at $4.44 per share, giving it a market capitalization of just under $85 million. Yet the company has some $65 million in cash and securities on its balance sheet, net of its exposure to a small line of credit, putting its enterprise value below $20 million....

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details